Fingerprint
Dive into the research topics where Steve Oghumu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
X chromosome inactivation in sex disparities to substance use disorder
Oghumu, S. (PI)
National Institute on Drug Abuse
08/15/21 → 05/31/26
Project: Research
-
Mechanisms of Oral Cancer Inhibition by Bioactive Phytochemicals in Black Raspberries
Oghumu, S. (PI)
09/1/17 → 08/31/18
Project: Research
-
PI3Kγ inhibition drives M1 macrophage differentiation and synergizes with PD-L1 blockade to improve survival in poorly immunogenic head and neck squamous cell carcinoma
Jordanides, P. P., Jagadeesha, S., Upadhaya, P., Ryan, N. M., Anderson, K., Lamenza, F. F., Shrestha, S., Siddiqui, A., Bopp, A. R., Pracha, S. H., Roth, P., Kehres, R., Mo, X. & Oghumu, S., 2026, In: Cancer Biology and Therapy. 27, 1, 2600701.Research output: Contribution to journal › Article › peer-review
Open Access -
Analysis of head and neck cancer scRNA-seq data identified PRDM6 promotes tumor progression by modulating immune gene expression
Wu, Z., Lepcha, T. T., Zhou, D., He, Z., Fiches, G. N., Park, Y., He, J., Chen, J., Shanaka, K. A. S. N., Oghumu, S., Zhao, W., Ma, A., Ma, Q., Zhu, J. & Santoso, N. G., 2025, In: Frontiers in immunology. 16, 1596916.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Durable Response to Pazopanib (Tyrosine Kinase Inhibitor) in a Patient With EWSR1::CREM Gene Fusion Positive Intra-Abdominal Unclassified Epithelioid Sarcoma
Shafi, S., Jones, D., Pan, X., Husain, M., Rogers, A., Oghumu, S. & Iwenofu, O. H., Oct 2025, In: Genes Chromosomes and Cancer. 64, 10, e70062.Research output: Contribution to journal › Review article › peer-review
Open Access -
Efficacy of anti-LAG3 and anti-PD-1 combination checkpoint inhibitor therapy against head and neck squamous cell carcinoma in a genetically engineered mouse model
Lamenza, F. F., Roth, P., Upadhaya, P., Shrestha, S., Jagadeesha, S., Kazmierowicz, N., Horn, N., Pracha, H., Dasari, S. & Oghumu, S., 2025, In: OncoImmunology. 14, 1, 2477872.Research output: Contribution to journal › Article › peer-review
Open Access7 Link opens in a new tab Scopus citations -
Inhibition of head and neck squamous cell carcinoma by Bruton’s tyrosine kinase inhibitor ibrutinib is associated with reduction of immunosuppressive T cells
Bopp, A. R., Lamenza, F. F., Upadhaya, P., Ryan, N. M., Kazmierowicz, N., Jordanides, P. P., Siddiqui, A., Pracha, S. H., Roth, P., Iwenofu, O. H. & Oghumu, S., Jul 2025, In: Cancer Immunology, Immunotherapy. 74, 7, 227.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations